Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT

NCT05931302 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer as lead sponsor.

NCT NCT05931302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05931302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 16, 2023
Completion date
November 30, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lobular breast carcinoma